Transcenta raises $100m led by Fortune Capital, CR-CP Life Science Fund

Transcenta raises $100m led by Fortune Capital, CR-CP Life Science Fund

Transcenta Holding Ltd (Transcenta), a global biotherapeutics company

Transcenta Holding Ltd (Transcenta), a global biotherapeutics company, has secured $100 million in its Series B+ round of financing led by Fortune Capital and CR-CP Life Science Fund, per a company statement. 

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter